Madrigal shares data from open-label study for its liver disease therapy resmetirom
November 12 2021 - 9:56AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Sep 2023 to Sep 2024